Literature DB >> 35665875

Melatonin Alleviates Ovariectomy-Induced Cardiovascular Inflammation in Sedentary or Exercised Rats by Upregulating SIRT1.

Sevil Arabacı Tamer1,2,3, Tülin Altınoluk1,3, Miray Emran4, Seda Korkmaz4, Rozerin Göze Yüksel4, Zeynep Baykal4, Zehra Sena Dur4, Hilal Nişva Levent5, Mürüvvet Abbak Ural6, Meral Yüksel7, Özge Çevik6, Feriha Ercan5, Alper Yıldırım1, Berrak Ç Yeğen8.   

Abstract

We aimed to evaluate the impact of hormone replacement, melatonin, or exercise alone or their combination on oxidative damage and functional status of heart, brain, and aorta of ovariectomized (OVX) rats and to determine whether the signaling pathway is dependent on sirtuin-1 (SIRT1). Ovariectomized Sprague Dawley rats were orally given either a hormone replacement therapy (1 mg/kg/day,17β estradiol; HRT) or melatonin (4 mg/kg/day) or HRT + melatonin treatments or tap water, while each group was further divided into sedentary and exercise (30 min/5 days/week) groups. After the heart rate measurements and memory tests were performed, trunk blood was collected at the end of the 10th week to determine metabolic parameters in serum samples. Tissue samples of abdominal aorta, heart, and brain were taken for biochemical measurements and histopathological evaluation. Heart rates and memory performances of the OVX rats were not changed significantly by none of the applications. Melatonin treatment or its co-administration with HRT upregulated the expressions of IL-10 and SIRT1, reduced the expressions of IL-6 and TNF-α, and reduced DNA damage in the hearts and thoracic aortae of non-exercised rats. Co-administration of melatonin and HRT to exercised OVX rats reduced inflammatory response and upregulated SIRT1 expression in the aortic and cardiac tissues. The present study suggests that melatonin treatment, either alone or in combination with exercise and/or HRT, upregulates SIRT1 expression and alleviates oxidative injury and inflammation in the hearts and aortas of OVX rats. Melatonin should be considered in alleviating cardiovascular disease risk in postmenopausal women.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  cardiovascular disease; exercise; hormone replacement therapy; melatonin; sirtuin-1

Year:  2022        PMID: 35665875     DOI: 10.1007/s10753-022-01685-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  71 in total

Review 1.  To exercise, or, not to exercise, during menopause and beyond.

Authors:  Lily Stojanovska; Vasso Apostolopoulos; Remco Polman; Erika Borkoles
Journal:  Maturitas       Date:  2014-01-24       Impact factor: 4.342

2.  Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.

Authors:  Di Zhao; Eliseo Guallar; Pamela Ouyang; Vinita Subramanya; Dhananjay Vaidya; Chiadi E Ndumele; Joao A Lima; Matthew A Allison; Sanjiv J Shah; Alain G Bertoni; Matthew J Budoff; Wendy S Post; Erin D Michos
Journal:  J Am Coll Cardiol       Date:  2018-06-05       Impact factor: 24.094

3.  Melatonin supports alendronate in preserving bone matrix and prevents gastric inflammation in ovariectomized rats.

Authors:  Esra Bihter Gürler; Özlem Tuğçe Çilingir-Kaya; Irem Peker Eyüboglu; Feriha Ercan; Mustafa Akkiprik; Russell J Reiter; Berrak Ç Yegen
Journal:  Cell Biochem Funct       Date:  2019-02-27       Impact factor: 3.685

4.  Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.

Authors:  Michael C Honigberg; Seyedeh Maryam Zekavat; Krishna Aragam; Phoebe Finneran; Derek Klarin; Deepak L Bhatt; James L Januzzi; Nandita S Scott; Pradeep Natarajan
Journal:  JAMA       Date:  2019-12-24       Impact factor: 56.272

Review 5.  Molecular and cellular basis of cardiovascular gender differences.

Authors:  Michael E Mendelsohn; Richard H Karas
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

Review 6.  Menopause and cardiovascular disease: the evidence.

Authors:  G M C Rosano; C Vitale; G Marazzi; M Volterrani
Journal:  Climacteric       Date:  2007-02       Impact factor: 3.005

7.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Authors:  JoAnn E Manson; Rowan T Chlebowski; Marcia L Stefanick; Aaron K Aragaki; Jacques E Rossouw; Ross L Prentice; Garnet Anderson; Barbara V Howard; Cynthia A Thomson; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson; Marian Limacher; Karen L Margolis; Sylvia Wassertheil-Smoller; Shirley A Beresford; Jane A Cauley; Charles B Eaton; Margery Gass; Judith Hsia; Karen C Johnson; Charles Kooperberg; Lewis H Kuller; Cora E Lewis; Simin Liu; Lisa W Martin; Judith K Ockene; Mary Jo O'Sullivan; Lynda H Powell; Michael S Simon; Linda Van Horn; Mara Z Vitolins; Robert B Wallace
Journal:  JAMA       Date:  2013-10-02       Impact factor: 56.272

8.  Decline in endothelial function across the menopause transition in healthy women is related to decreased estradiol and increased oxidative stress.

Authors:  Kerrie L Moreau; Kerry L Hildreth; Jelena Klawitter; Patrick Blatchford; Wendy M Kohrt
Journal:  Geroscience       Date:  2020-08-08       Impact factor: 7.713

9.  Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.

Authors:  Balasunder R Dodda; Corry D Bondi; Mahmud Hasan; William P Clafshenkel; Katie M Gallagher; Mary P Kotlarczyk; Shalini Sethi; Ethan Buszko; Jean J Latimer; J Mark Cline; Paula A Witt-Enderby; Vicki L Davis
Journal:  Front Oncol       Date:  2019-07-09       Impact factor: 6.244

Review 10.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.

Authors:  Gregory A Roth; George A Mensah; Catherine O Johnson; Giovanni Addolorato; Enrico Ammirati; Larry M Baddour; Noël C Barengo; Andrea Z Beaton; Emelia J Benjamin; Catherine P Benziger; Aimé Bonny; Michael Brauer; Marianne Brodmann; Thomas J Cahill; Jonathan Carapetis; Alberico L Catapano; Sumeet S Chugh; Leslie T Cooper; Josef Coresh; Michael Criqui; Nicole DeCleene; Kim A Eagle; Sophia Emmons-Bell; Valery L Feigin; Joaquim Fernández-Solà; Gerry Fowkes; Emmanuela Gakidou; Scott M Grundy; Feng J He; George Howard; Frank Hu; Lesley Inker; Ganesan Karthikeyan; Nicholas Kassebaum; Walter Koroshetz; Carl Lavie; Donald Lloyd-Jones; Hong S Lu; Antonio Mirijello; Awoke Misganaw Temesgen; Ali Mokdad; Andrew E Moran; Paul Muntner; Jagat Narula; Bruce Neal; Mpiko Ntsekhe; Glaucia Moraes de Oliveira; Catherine Otto; Mayowa Owolabi; Michael Pratt; Sanjay Rajagopalan; Marissa Reitsma; Antonio Luiz P Ribeiro; Nancy Rigotti; Anthony Rodgers; Craig Sable; Saate Shakil; Karen Sliwa-Hahnle; Benjamin Stark; Johan Sundström; Patrick Timpel; Imad M Tleyjeh; Marco Valgimigli; Theo Vos; Paul K Whelton; Magdi Yacoub; Liesl Zuhlke; Christopher Murray; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2020-12-22       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.